[Drug-induced systemic lupus erythematosus (author's transl)].
D000293:Adolescent; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000917:Antibody Formation; D001323:Autoantibodies; D002648:Child; D002746:Chlorpromazine / Q000009:adverse effects; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D007108:Immune Tolerance / Q000187:drug effects; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000276:immunology; D008750:Methyldopa / Q000009:adverse effects*; D011217:Practolol / Q000009:adverse effects; D011342:Procainamide / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D001323:Autoantibodies; D006830:Hydralazine; D008750:Methyldopa; D011342:Procainamide; D011217:Practolol; D002746:Chlorpromazine
Drogeninduzierter systemischer Lupus erythematodes.